Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.305 USD | -1.79% | +4.41% | -31.20% |
20/03 | Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing | MT |
19/03 | Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance | MT |
Business Summary
Number of employees: 676
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Full Spectrum Flow Cytometry Platform
81.2
%
| 149 | 90.6 % | 157 | 81.2 % | +5.46% |
Service
18.8
%
| 15 | 9.4 % | 36 | 18.8 % | +135.15% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
52.9
%
| 95 | 57.7 % | 102 | 52.9 % | +7.92% |
EMEA
27.6
%
| 44 | 26.8 % | 53 | 27.6 % | +20.97% |
APAC
16.4
%
| 23 | 13.7 % | 32 | 16.4 % | +40.29% |
Other
3.2
%
| 3 | 1.8 % | 6 | 3.2 % | +107.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ming Yan
FOU | Founder | 61 | 01/14/01 |
Wen Bin Jiang
FOU | Founder | 60 | 01/14/01 |
Chris Williams
COO | Chief Operating Officer | 55 | 31/22/31 |
Paul Goodson
IRC | Investor Relations Contact | - | - |
Philippe Busque
SAM | Sales & Marketing | - | 28/23/28 |
Connie Wedel
HRO | Human Resources Officer | - | - |
Melik Ulusu
PRN | Corporate Officer/Principal | - | 01/20/01 |
Allen Poirson
PRN | Corporate Officer/Principal | 64 | 13/18/13 |
Valerie Barnett
LAW | General Counsel | 49 | 01/21/01 |
Patrik Jeanmonod
PRN | Corporate Officer/Principal | 58 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donnie Hardison
BRD | Director/Board Member | 74 | 01/22/01 |
Deborah Neff
BRD | Director/Board Member | 71 | - |
Jack Ball
BRD | Director/Board Member | 77 | 13/18/13 |
Allen Poirson
PRN | Corporate Officer/Principal | 64 | 13/18/13 |
Wen Bin Jiang
FOU | Founder | 60 | 01/14/01 |
Gisele Dion
BRD | Director/Board Member | 57 | 01/21/01 |
Ming Yan
FOU | Founder | 61 | 01/14/01 |
Vera Imper
BRD | Director/Board Member | 62 | 31/21/31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 131,264,277 | 119,888,200 ( 91.33 %) | 0 | 91.33 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.20% | 843M | |
+8.00% | 219B | |
+6.88% | 183B | |
+14.71% | 136B | |
+26.83% | 107B | |
-2.09% | 63.07B | |
+7.76% | 52.55B | |
+12.29% | 51.28B | |
+0.84% | 41.21B | |
+4.63% | 36.43B |
- Stock Market
- Equities
- CTKB Stock
- Company Cytek Biosciences, Inc.